Im really concerned about the way in which this market has developed that compromises public safety, said Australias federal health minister, Mark Butler, when the ban was announced
Track symptoms and call your care team : Watch for nausea, dizziness, weakness, confusion, or fainting, and stay connected if youre experiencing side effects or changes in glucose
Rarely clinically significant
Discover the key differences between retatrutide and semaglutide to find out which is right for you
Patients requiring multifactorial risk management : Individuals with multiple cardiovascular risk factors may benefit from the pleiotropic effects of GLP-1 therapy, including blood pressure reduction, weight loss, and lipid improvements
Petersburg wanting innovative options in their weight loss journey